UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of June 2024
Commission File Number: 001-39446
CureVac N.V.
(Exact Name of Registrant as Specified in Its Charter)
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
+49 7071 9883 0
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form 40-F ¨
On June 24, 2024, CureVac N.V. (the “Company”) issued a table containing tabulations of the votes cast at the Company’s annual general meeting of shareholders.
The information included in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CUREVAC N.V. | ||
| By: | /s/ Alexander Zehnder | |
| Chief Executive Officer | ||
Date: June 26, 2024
EXHIBIT INDEX
| EXHIBIT NO. | DESCRIPTION | |
| 99.1 | Final Tabulation Table of Votes Cast on the Company’s Annual General Meeting of Shareholders. |
Exhibit 99.1
CureVac N.V., Tübingen, Germany General Meeting of Shareholders, June 24, 2024 |  |
Voting results – Overview
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2023 - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.753.185 | Yes votes | 99.98 % of the valid votes cast | |
| 20.809 | No votes | 0.01 % of the valid votes cast | |
| Agenda Item 5 | Release of managing directors from liability for the exercise of their duties during the financial year 2023 - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.681.577 | Yes votes | 99.94 % of the valid votes cast | |
| 77.528 | No votes | 0.05 % of the valid votes cast | |
| Agenda Item 6 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2023 - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.521.679 | Yes votes | 99.83 % of the valid votes cast | |
| 237.388 | No votes | 0.16 % of the valid votes cast | |
| Agenda Item 7 | Appointment of Thaminda Ramanayake as member of the Company´s management board - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.678.411 | Yes votes | 99.89 % of the valid votes cast | |
| 147.582 | No votes | 0.10 % of the valid votes cast | |
| Agenda Item 8 | Reappointment of Malte Greune as member of the Company's management board - accepted | ||
| 144.861.797 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.667.548 | Yes votes | 99.89 % of the valid votes cast | |
| 157.977 | No votes | 0.10 % of the valid votes cast | |
1
CureVac N.V., Tübingen, Germany General Meeting of Shareholders, June 24, 2024 | |
| Agenda Item 9 | Reappointment of Jean Stéphenne as member of the Company's supervisory board - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58% of the registered share capital) | ||
| 138.088.175 | Yes votes | 95.34 % of the valid votes cast | |
| 6.737.347 | No votes | 4.65 % of the valid votes cast | |
| Agenda Item 10 | Reappointment of Mathias Hothum as member of the Company's supervisory board - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 137.885.797 | Yes votes | 95.20 % of the valid votes cast | |
| 6.938.247 | No votes | 4.79 % of the valid votes cast | |
| Agenda Item 11 | Appointment of Birgit Hofmann as member of the Company's supervisory board - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 140.609.613 | Yes votes | 97.08 % of the valid votes cast | |
| 4.216.013 | No votes | 2.91 % of the valid votes cast | |
| Agenda Item 12 | Reappointment of the external auditor for the financial year 2025 - accepted | ||
| 144.861.897 | Number of shares for which valid votes were cast (= 64.58 % of the registered share capital) | ||
| 144.804.320 | Yes votes | 99.98 % of the valid votes cast | |
| 21.405 | No votes | 0.01 % of the valid votes cast | |
2